Published trade mark details for 2661498
This information was published on 2026-06-11T02:16:48 for IP Right Filed Published.
| Field | Value |
| (210) | 2661498 (IR 1922067) |
| (220) |
17 Apr 2026
|
| (300) |
TO, 28 Oct 2025, TO/M/2025/004971
|
| (500) |
The mark consists of stylized letter "D" made of small squares.
|
| (511) (510) |
Class 5
Pharmaceuticals; pharmaceutical preparations; pharmaceuticals for the treatment of mental health conditions; pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, depression, post-traumatic stress disorder, and mood disorders; pharmaceutical preparations for the treatment of substance-use and addictive disorders. Class 42 Drug discovery services; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the fields of psychiatry, neurology, and addiction medicine; medical and scientific research, namely, conducting clinical trials for others in the field of psychedelic-based therapeutics. |
| (540) |
|
| (550) | Figurative |
| (730) |
Definium Therapeutics US, Inc.
|
Find out more about publications on the About page.